Development and evaluation of gastroretentive norfloxacin floating tablets

Acta Pharmaceutica

Volumn 59, Issue 2, 2009, Pages 211-221

  Bomma, Ramesh ^a,b   Swamy Naidu, Rongala ^b   Yamsani, Madhusudan ^a   Veerabrahma, Kishan ^a  

^a KAKATIYA UNIVERSITY   (India)

^b NATCO   (India)

Author keywords

Floating tablets; Gastric residence time; Gastroretentive drug delivery system; Norfloxacin

Indexed keywords

BARIUM SULFATE; HYDROXYPROPYLMETHYLCELLULOSE; NORFLOXACIN; POLYMER;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RETENTION; DRUG SCREENING; DRUG SYNTHESIS; GRANULATION TISSUE; HARDNESS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; TABLET FORMULATION; THICKNESS;

EID: 67651172877     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0019-6     Document Type: Article

References (18)

1. S. Baumgartner, J. Kristl, F. Vrecer, P. Vodopivec and B. Zorko, Optimization of floating matrix tablets and evaluation of their gastric residence time, Int. J. Pharm. 195 (2000) 125-135; DOI: 10.1016/S0378-5173(99)00378-6.
2. B. N. Sing and K. H. Kim, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention, J. Control. Rel. 63 (2000) 235-259; DOI: 10.1016/S0168-3659(99)00204-7.
3. A. Rubinstein and D. R. Friend, Specific Delivery to the Gastrointestinal Tract, in Polymeric Site-Specific Pharmacotherapy (Ed. A. J. Domb), Wiley, Chichester 1994, pp. 283-285.
4. W. A. Ritschel, Targeting in the gastrointestinal tract: new approaches, Methods Find, Exp. Clin. Pharmacol. 13 (1991) 313-316.
5. C. Mahesh, J. Paras, C. Sachin, S. Rajesh and V. Pradeep, Development of sustained release ga-stroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation, Int. J. Pharm. 304 (2005) 178-184; DOI: 10.1016/j.ijpharm.2005.08.009.
6. J. Varshosaz, N. Tavakoli and F. Roozbahani, Formulation and in vitro characterization of cipro-floxacin floating and bioadhesive extended-release tablets, Drug Del. 13 (2006) 277-285; DOI: 10.1080/10717540500395106.
7. K. M. Gerald, Norfloxacin, in AHFS Drug Information, The American Society of Health System Pharmacists, Bethesda 2004, pp. 396-402.
8. C. Mazuel, Norfloxacin, in Analytical Profiles of Drug Substances (Ed. K. Florey), Vol. 20, Academic Press, San Diego 1991, pp. 557-600.
9. st ed., Thomson PDR, Montvale 2007, pp. 2032-2038.
10. United States Pharmacopeia 28, National Formulary 23, USP Convention, Rockville 2005, pp. 2745.
11. T. Higuchi, Rate of release of medicaments from ointment bases containing drugs in suspensions, J. Pharm. Sci. 50 (1961) 874-875.
12. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378--5173(83)90064-9.
13. N. A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv. 60 (1985) 110-111.
14. L. Whitehead, J. T. Fell, J. H. Collett, H. L. Sharma and A. M. Smith, Floating dosage forms: an in vivo study demonstrating prolonged gastric retention, J. Control. Rel. 55 (1998) 3-12; DOI: 10.1016/S0168-3659(97)00266-6.
15. th ed., Vol. 2, Lippincott, Williams and Wilkins, Philadelphia 2000, pp. 1660-1675.
16. J. W. Moore and H. H. Flanner, Mathematical comparison of curves with an emphasis on in vitro dissolution profiles, Pharm. Technol. 20 (1996) 64-74.
17. Guidance for Industry (Dissolution Testing of Immediate Release Solid Oral Dosage Forms), US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation Research (CDER), Aug 1997, pp. 9; www.fda.gov/cder/guidance.htm; access date April 22, 2009.
18. K. Mitchell, J. L. Ford and D. J. Armstrong, The influence of concentration on the release of drugs from gels and matrices containing Methocel, Int. J. Pharm. 100 (1993) 155-163; DOI: 10.1016/ 0378-5173(93)90086-U.